valine has been researched along with Dyskinesia Syndromes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cances, C; Damaj, L; de Lonlay, P; Doummar, D; Espil, C; Fluss, J; François-Heude, MC; Kern, I; Lebigot, E; Leboucq, N; Lenaers, G; Meyer, P; Munnich, A; Roubertie, A; Roze, E; Spitz, MA; Torre, S; Touati, G; Warde, MTA | 1 |
| Jimenez-Shahed, J; Tarakad, A | 1 |
| Correll, CU; Kane, JM; Lencz, T; Malhotra, AK; Miura, I; Nitta, M; Yabe, H; Zhang, JP | 1 |
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
| Burke, J; Castro-Gayol, JC; Factor, SA; Hauser, RA; Jimenez, R; Mandri, D; O'Brien, CF | 1 |
| An, H; Cho, SN; Choi, JE; Han, C; Joe, SH; Jung, IK; Kang, SG; Kim, L; Kim, SH; Kim, YK; Lee, HJ; Lee, MS; Park, YM | 1 |
| Cramer, SC; McHughen, SA; Ngo, VK; Pearson-Fuhrhop, K | 1 |
| Chen, DC; Haile, CN; Kosten, TA; Kosten, TR; Wu, HR; Xiu, MH; Zhang, WF; Zhang, XY; Zhou, DF | 1 |
| Botes, WC; Deleuze, JF; Hitzeroth, A; Koen, L; Niehaus, DJ; Warnich, L | 1 |
| Cusick, PK; Ferrier, B; Haskell, BE; Koehler, KM | 1 |
3 review(s) available for valine and Dyskinesia Syndromes
| Article | Year |
|---|---|
VMAT2 Inhibitors in Neuropsychiatric Disorders.
Topics: Antipsychotic Agents; Basal Ganglia; Humans; Mental Disorders; Movement Disorders; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2018 |
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Databases, Bibliographic; Female; Genotype; Humans; Male; Methionine; Middle Aged; Movement Disorders; Polymorphism, Single Nucleotide; Schizophrenia; Severity of Illness Index; Valine | 2014 |
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
2 trial(s) available for valine and Dyskinesia Syndromes
| Article | Year |
|---|---|
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Tetrabenazine; Treatment Outcome; Valine; Vesicular Biogenic Amine Transport Proteins; Young Adult | 2015 |
Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; China; Female; Genotype; Ginkgo biloba; Humans; Male; Methionine; Middle Aged; Movement Disorders; Pharmacogenetics; Plant Extracts; Polymorphism, Genetic; Predictive Value of Tests; Regression Analysis; Schizophrenia; Severity of Illness Index; Treatment Outcome; Valine | 2012 |
5 other study(ies) available for valine and Dyskinesia Syndromes
| Article | Year |
|---|---|
Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies.
Topics: Abnormalities, Multiple; Amino Acid Metabolism, Inborn Errors; Chorea; Coenzyme A; Dystonia; Dystonic Disorders; Enoyl-CoA Hydratase; Humans; Leigh Disease; Movement Disorders; Thiolester Hydrolases; Valine | 2022 |
Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
Topics: Adult; Alanine; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Korea; Logistic Models; Male; Middle Aged; Movement Disorders; Polymorphism, Genetic; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Superoxide Dismutase; Valine | 2008 |
Intense training overcomes effects of the Val66Met BDNF polymorphism on short-term plasticity.
Topics: Amino Acid Sequence; Brain-Derived Neurotrophic Factor; Female; Genetic Testing; Humans; Longitudinal Studies; Male; Methionine; Motor Cortex; Movement Disorders; Neuronal Plasticity; Physical Education and Training; Polymorphism, Single Nucleotide; Valine; Young Adult | 2011 |
Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Topics: Adult; Africa, Southern; Alanine; Chi-Square Distribution; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Movement Disorders; Polymorphism, Genetic; Schizophrenia; Superoxide Dismutase; Valine | 2007 |
The neurotoxicity of valine deficiency in rats.
Topics: Animals; Isoleucine; Leucine; Male; Movement Disorders; Nervous System; Rats; Red Nucleus; Tryptophan; Valine | 1978 |